Forward-thinking pharmaceutical manufacturer committed to excellence
Pharmaceutical pellets and DC granules with advanced formulation technology
Being the most respected company in pharmaceutical formulations globally
Our core objective is to meet customer demands for quality, affordability, and timely delivery
WHO-GMP compliance with strict adherence to Schedule M requirements
30,000 sq ft facility with microprocessor-controlled Wurster coaters ensuring precision
Dedicated space for developing new formulations with cutting-edge technology
Advanced area for conducting analytical research and comprehensive testing
State-of-the-art laboratories ensuring the highest quality standards
WHO-GMP compliant production with strict adherence to Schedule M
Comprehensive range of pharmaceutical pellets with manufacturing licenses
8.5% w/w & 7.50% w/w (IP/USP/BP)
22% & 32.25% w/w (IP/USP/BP)
8.5% w/w (IP/BP)
8.5% w/w (IP/BP/USP)
22.5% & 30% w/w (IP/USP)
15.4% w/w (IP/BP/USP)
50.0% w/w (IP/BP/USP)
15.0% w/w (IP/BP/USP)
15.0% w/w (IP/BP/USP)
50.0% w/w (USP)
17.5% & 22.0% w/w (IP/BP)
40.0% w/w (IP/BP/USP)
22.5% w/w (USP)
Pantoprazole + Domperidone, Rabeprazole + Domperidone
Experienced professionals dedicated to driving innovation and growth
PhD, Chairman & Chief Mentor
Guiding Overall Strategy
Co-Chairman - Operations Excellence
Driving Operations & Compliance
Managing Director
Marketing, Sales & Strategy
Director
Operations, HR & SOPs
Committed to protecting intellectual property rights
NDAs with clients on need basis
All employees sign NDAs and pledge confidentiality
Belief in transparency and ethical business practices
Plot No. 203/6, Phase-II, Sector-III
I.P Cherlapally, Hyderabad
Telangana - 500051, India
+91 8008948383
+91 9346324191
shiva.hosur@bluehawklifesciences.com
GSTIN: 36AAKCB2855R1ZY
PAN: AAKCB2855R
CIN: U24110TS2021PTC186540
TAN: HYDB11399D